Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

Condition:   Non-Valvular Atrial Fibrillation Interventions:   Drug: Rivaroxaban (Xarelto, BAY-597939);   Drug: VKAs Sponsors:   Bayer;   Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials